Admission Date:  [**2151-9-18**]              Discharge Date:   [**2151-9-23**]  Date of Birth:  [**2074-5-1**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**Doctor First Name 2080**] Chief Complaint: Transfer from [**Location (un) 47**] for cholangitis  Major Surgical or Invasive Procedure: ERCP with stent placement Central line placement  History of Present Illness: This is a 77 year-old male with a history of cholecysectomy in [**2143**] and subsequent ERCP in [**2143**] & [**2148**] for stones, AVR/MVR, CABG, AICD, hyperlipidemia,m COPD presented to [**Hospital1 **] with abdominal pain x2 days and transferred to [**Hospital1 18**] for cholangitis and ERCP.
The patient was started on IVF 500cc bolus.
Baseline SOB, unchanged from prior The patient denies any weight change, nausea, vomiting, abdominal pain, diarrhea, constipation, melena, hematochezia, chest pain, orthopnea, PND, lower extremity edema, cough, urinary frequency, urgency, dysuria, lightheadedness, gait unsteadiness, focal weakness, vision changes, headache, rash or skin changes.
Past Medical History: Coronary artery disease s/p Coronary Artery Bypass Graft [**2127**] & [**2137**] (PTCA/stent to SVG to PDA graft [**2-18**]) with redo sternotomy x2 and coronary artery bypass graft x1 (SVG>PDA) in [**5-19**] Mitral valve repair [**5-19**] AVR (tissue valve) redo in [**5-19**] Atrial fibrillation (off anti-coagulation [**3-15**] GI bleed) Cardiomyopathy Hyperlipidemia Chronic Obstructive Pulmonary Disease Gastroesophageal Reflux Disease Hypertension GI bleed Renal insufficiency (baseline Cr 1.5-1.9)  Past Surgical History: Cholecystectomy [**2143**] Back Surgery Nasal Surgery Eye Surgery  Social History: Currently smokes 10 cigs/day and 1ppd since at 18yrs.
Pertinent Results: On admission to [**Hospital Unit Name 153**]: [**2151-9-19**] 04:32AM WBC-16.2*# RBC-3.56* Hgb-11.3* Hct-33.9* MCV-95 MCH-31.6 MCHC-33.2 RDW-14.1 Plt Ct-86* Glucose-130* UreaN-46* Creat-2.8* Na-139 K-5.1 Cl-107 HCO3-18* AnGap-19 ALT-132* AST-137* LD(LDH)-264* AlkPhos-125* TotBili-6.6* Lactate-2.9*  [**9-19**] ERCP: Pus, sludge and one stone were released from the bile duct following cannulation - consistent with cholangitis (cannulation) Previous sphincterotomy at the major papilla Multiple filling defects in the CBD consistent with stones and sludge were seen A 5cm 10F double pigtail stent was successfully placed in the common hepatic duct for drainage (stent placement) Otherwise normal ercp to third part of the duodenum *repeat ERCP in 4 weeks for stent removal and stone extraction.
Followup PA and lateral radiographs would be helpful for initial further evaluation.
A pig tail biliary stent was placed in the common hepatic duct.
Patient was intubated for procedure, and was extubated the same day without difficulty.
Zosyn was continued on transfer (started [**9-18**]) and converted to Ciprofloxacin 500mg po Q12H on [**9-22**].
Of note, patient's alkaline phosphatase continued to rise during hospitalization (in three days prior to admission 225, 438, and 480 on discharge).
Home ACEI, Beta Blocker were held on admission.
Required Vaso/Norepinephrine initially.
Also required Dopamine post-ERCP.
Dopamine was weaned on HD2 and Vaso/Norepinephrine weaned HD3.
#AoCRF: Noted to be ARF on admission (Cr 2.7) which returned to baseline (baseline Cr 1.7-2) with aggressive IVF hydration, BP support.
Of note, there are prior reports of prosthetic valve related thrombocytopenia (?auto-immune mechanism).
No clear mechanism of marrow hypo-proliferation or destruction.
#AF: Initial rate-control [**Doctor Last Name 360**] (Metoprolol) was held [**3-15**] hypotension on admission.
Home dose metoprolol 25mg [**Hospital1 **] was re-started on HD4.
Patient's ASA 325mg was continued and further anti-coagulation was deferred per home regimen given hx of significant GIB.
Home dose ACEI, statin were held initially.
Patient's statin was held during hospitalization given transaminitis.
Day prior to discharge patient received Lasix 20mg IV with notable diuresis and subjective improvement of dyspnea.
He also received Atrovent and Albuterol Q6H during hospitalization.
Medications on Admission: Zetia 10mg daily ASA 325mg daily Vit B12 250mg daily Gemfibrzole 600mg [**Hospital1 **] Folic Acid 1mg QID Simvastatin 80mg daily Lisinopril 5mg daily Metoprolol 25mg daily   Discharge Medications: 1.
Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 10 days.
Ipratropium Bromide 17 mcg/Actuation Aerosol Sig: One (1) Inhalation every 4-6 hours as needed for shortness of breath or wheezing: Use inhaler every 4-6 hours for shortness of breath or wheezing.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for Constipation.
Lasix 20 mg Tablet Sig: One (1) Tablet PO once a day as needed for lower extremity swelling, shortness of breath.
Simvastatin 80 mg Tablet Sig: One (1) Tablet PO once a day.
Gemfibrozil 600 mg Tablet Sig: One (1) Tablet PO twice a day.
Zetia 10 mg Tablet Sig: One (1) Tablet PO once a day.
You underwent an ERCP with drainage of the infected material, and a plastic stent was placed in the bile duct to help clear and drain the infected material.
You received antibiotics after the procedure and will continue them for a total of 14 days--last day is [**2151-10-2**].
New medications started during your hospitalization: 1.
Ciprofloxacin 500mg po Q12H .
Followup Instructions: Please follow-up with the GI service in 3 weeks for removal of the temporary stent placed in your bile duct.
